@B_Dogs4@healingfromlc@lsthart This seems like a good distinction to me. Invisible *disability* makes more sense than invisible illness because society stereotypically expects disabilities to be extremely obvious. Whereas like Celine said as overall illnesses go LC is not particularly invisible.
Of all the people infected, six months later:
- 4.5% had full-blown ME
- 39.8% had ME-like illness
- 55.7% did not have any ME symptoms
This is much higher than the numbers among uninfected people (0.6%, 16.1%, and 83.3% respectively)
Committed to exploring all immunological causes of her condition, Alina traveled to see Ludger Tebartz van Elst, a neuropsychiatrist at the Albert Ludwig University of Freiburg in Germany specializing in identifying and treating autoantibodies that attack the brain.
“How a neuroscientist solved the mystery of his own long COVID”
“More tests revealed the identity of the antibody causing Jeff’s symptoms: an antibody that binds to neurofascin 155…”
https://t.co/Y9RhLiEueG
Doctors don’t evaluate the seriousness of a symptom based on its severity or impact, but according to whether they recognise it as indicative of a specific disease type. So you’re going to get more treatment for a very specific rash than for being literally bedbound with ME
@mecfsskeptic Interesting, I was just reading today about how elevated Platelet-Derived Growth Factor *receptor* beta might be a marker of BBB dysfunction (though I think they're collecting it from cerebrospinal fluid). https://t.co/5W30SIgdra
A reanalysis of the oxaloacetate trial for #LongCovid and #MECFS
As promised, I’m now sharing my findings. Here’s a summary of what’s wrong with this trial.
(If you want to dive into the report I sent to the editor of the journal ➡️ https://t.co/D9zEIjpyq4)
🧵 1/23
Northwestern: New research shows younger & middle-aged adults have worse long COVID symptoms than older adults
These findings have an immense public health impact, given that long COVID significantly contributes to the leading global burden of disability
https://t.co/9ljdIF2jLS
@Sabrina_Poirier Are you measuring it during the day or at night Personally, my average sleeping HRV as recorded by my oura ring has tracked my decline pretty well. (When I was healthy it averaged above 60, now it's around 20). But I wouldn't be surprised if it's only reliable for a subset of us.
@cstroeckw Jarred Younger put out a video recently about a meta analysis on adrenaline in MECFS. Sounds like he thinks there might be a subtype with elevated adrenaline. https://t.co/o5mwIHSTAb
@fcknsyd @daringshift @chydorina So happy it’s have an effect for you. I really hope they do more research into peroxidomes based on how prodrome glia seems to help a decent number of us…
Over the last month my HRV has been steadily increasing. (Besides the last 3 days because I started a new medication 😅).
The only thing I've changed? Adding plasmalogens. Prodrome Glia!!! I feel less concussed 24/7. Small but noticeable improvements.
@daringshift @chydorina
A good thread on the concept of:
"I can do a bit more because I've improved a little" -Vs- "I've improved a little because I've done a bit more."
Always important to recognise the two states exist, and not to automatically assume the latter.
@AndrewG76201347@Naomi_D_Harvey I get what you’re saying 😢. Certainly “feeling you can do more” does not imply we actually can. I just meant if I start doing more, and it works with no PEM, that that doesn’t mean I could have done more all along.